Paramyxoviruses hijack host RNA modifier to boost replication and evade immunity

Inside the cell, a quiet war plays out at the molecular level. Viruses need to replicate, and they do it by hijacking the machinery their hosts have built for their own survival. A team of researchers has now identified one of the most elegant tricks paramyxoviruses—a family that includes measles, mumps, and Nipah virus—use to turn the tables on their hosts.

The story begins with a protein called METTL3, which normally lives in the nucleus and marks messenger RNA with a chemical tag called m6A. This tag is like a postal code on an envelope: it tells the cell how to handle that RNA, affecting whether it gets translated into protein, how long it survives, and how it moves through the cell. For decades, scientists thought METTL3 did its work only in the nucleus. But paramyxoviruses replicate entirely in the cytoplasm, far from where METTL3 usually operates. The researchers discovered that when these viruses infect a cell, something remarkable happens: the viral matrix protein—a structural component of the virus itself—physically grabs METTL3, binds to it, and escorts it out of the nucleus into the cytoplasm, right to the viral replication factories. The virus essentially kidnaps the cell's own tagging machinery.

This hijacking serves two purposes at once, which is what makes it so sophisticated. First, once METTL3 is in the cytoplasm near the viral replication sites, it tags the virus's own messenger RNAs with m6A marks. The researchers showed that these marks, particularly on the viral nucleocapsid protein gene, make those viral transcripts more stable and more efficiently translated into protein. When they mutated the sites where m6A normally attaches, viral replication dropped sharply. The virus essentially uses the host's own tagging system to amplify its own gene expression. Second, and equally important, pulling METTL3 out of the nucleus depletes it from where it normally works. With less METTL3 in the nucleus, host genes don't get tagged properly. Most critically, the gene for interferon-beta—a central alarm signal that tells the immune system a virus is present—gets fewer m6A marks. Without those marks, interferon-beta mRNA is less stable and produces less protein. The virus has simultaneously boosted its own replication while muting the cell's distress call.

The researchers traced the molecular mechanics with precision. The viral matrix protein contains a nuclear export signal—essentially a postal code that tells the cell's export machinery to move it out of the nucleus. The protein binds to METTL3 at a specific region within METTL3's catalytic domain, then recruits a cellular transporter called exportin-1 to ferry both proteins out through the nuclear pore. When the researchers blocked this export pathway, either by mutating the viral protein's export signal or by inhibiting exportin-1 itself, METTL3 stayed in the nucleus and the virus couldn't replicate efficiently. The mechanism is conserved across multiple paramyxoviruses—Sendai virus, human parainfluenza virus type 3, Nipah virus, and measles virus all use the same trick, suggesting it evolved long ago and has been refined through millions of years of viral-host interaction.

What makes this discovery therapeutically interesting is its specificity. Rather than trying to block METTL3 itself—which would disrupt countless normal cellular processes—researchers could target the interaction between the viral matrix protein and METTL3. The researchers identified the exact amino acid region where the viral protein grabs METTL3, a region spanning just 53 amino acids. A drug designed to block this specific handshake could theoretically stop the virus without broadly disrupting the cell's own m6A machinery. The challenge, as the researchers acknowledge, is that the m6A system is woven into nearly every aspect of RNA metabolism in the cell. Even a targeted intervention might have unintended consequences. But the specificity of the viral-host interaction offers a window that doesn't exist with other antiviral approaches.

The work also reveals something broader about how viruses and cells coevolve. Paramyxoviruses solved a fundamental problem—they replicate in the cytoplasm, but the cell's most sophisticated RNA-processing machinery lives in the nucleus. Rather than evolving entirely new machinery, the virus simply learned to move the cell's existing machinery to where it needs it. It's a form of molecular theft that works because the virus has learned to speak the cell's own language. The researchers showed that this strategy is so important to the virus that mutations disrupting it cause the virus to replicate poorly, even when researchers tried to rescue it by supplying extra copies of the viral protein. The virus has become dependent on this hijacking. Understanding that dependency may be the key to stopping it.